Strong global surveillance by the WHO and CDC, showing no novel pathogen with sustained human-to-human transmission, underpins the 94.5% market-implied probability against a new 2026 pandemic. The Bundibugyo Ebola outbreak in the DRC, declared a PHEIC with over 4,500 cases, exhibits high case fatality but remains regionally contained due to contact tracing limits and lack of efficient spread beyond borders. COVID-19 activity stays moderate with declining trends, while avian influenza detections remain sporadic without pandemic adaptation. Measles and dengue surges reflect localized gaps rather than global emergence. Realistic challenges include undetected viral evolution enabling efficient transmission or major surveillance failures amid funding shortfalls, though current data favor containment through established response protocols.